CMC Advises Sidam on Sale to Synopo

Milan, Italy - CMC congratulates its client, Sidam S.r.l.  on the sale of the company to Synopo S.p.A.  Founded in 1991, Sidam manufactures highly innovative medical devices used in the contrast media delivery, infusion, special therapies and radioactive liquid preparation for major players in the medical device and biopharmaceutical sectors. CMC initiated the transaction with Synopo and acted as financial advisor to Sidam.  "We strongly believe the partnership with Synopo will boost Sidam's growth in the coming years," commented Graziano Azzolini, founder of Sidam. "Their significant presence as a distributor in the Italian medical device market creates numerous operational and strategic synergies with Sidam." Added Annalisa Azzolini, new CEO of Sidam S.r.l., "I am thrilled to have Synopo as our new partner and look forward to working with them to realize our ambitious longer-term strategic objectives". "The operating leverage that is achievable through the combination of Synopo and Sidam was a key consideration behind this transaction," stated Carlo Bonomi, President and CEO of Synopo S.p.A.  "Sidam is representative of Italian excellence in the medical device market globally and its expertise in R&D and manufacturing will help us become a major European player.  We are delighted to join with the Azzolini family." Studio Legale Laghi Leo e Associati is the legal advisor for both Synopo and Sidam in the transaction. 

About CMC Consulting Group

The CMC Group is an international advisory firm providing integrated transaction services, management and medical affairs consulting and contract research to companies in the life science industries.  This integration provides clients a seamless interface between strategy and implementation and incorporates a range of perspectives designed to optimize engagement outcomes.  With offices in the United States, Asia and throughout the EU, the firm complements global industry knowledge with rich local market insight.